Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Organ Directed Toxicities of Anticancer Drugs - Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer Drugs Burlington, Vermont, USA-June 4-6, 1987 (Hardcover, 1988 ed.)
Loot Price: R4,317
Discovery Miles 43 170
|
|
Organ Directed Toxicities of Anticancer Drugs - Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer Drugs Burlington, Vermont, USA-June 4-6, 1987 (Hardcover, 1988 ed.)
Series: Developments in Oncology, 53
Expected to ship within 12 - 17 working days
|
The addition of chemotherapy as an effective means to treat cancer
has had a major impact on selected human malignancies. Due to a
general inability to dif ferentiate between normal and neoplastic
cells, little selectivity exists in currently used oncolytic drugs.
Consequently, significant toxicity to the patient is expected when
systemic cancer chemotherapy is chosen as an appropriate
therapeutic in tervention. Much of this toxicity, such as damage to
the bone marrow, gastroin testinal tract, or hair follicles, is
predictable based upon the fact that anticancer drugs kill actively
dividing cells. These types of toxicities, while serious, are
usually manageable and reversible and are, therefore, not often
considered to be dose limiting. Unfortunately, several of the most
important anticancer drugs also damage tissues in which the growth
fraction is relatively small. Such toxicities can not be predicted
based on the chemical structure of the drugs, are often not
detected in preclinical studies, and are encountered frequently for
the first time in clinical studies. Further, unlike most of the
proliferative-dependent toxicities, the unpre dicted toxicities are
usually irreversible or only partially reversible upon cessation of
drug administration. Because of this, the unpredicted toxicities
are referred to as dose limiting. They represent a significant
barrier to the ultimate efficacy of several of our most important
anticancer drugs."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts
Paperback
R320
R295
Discovery Miles 2 950
Cancer
Susan E Pories, Marsha A Moses, …
Hardcover
R1,611
Discovery Miles 16 110
See more
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.